- Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound
- Mydecine Provides Q4 2023 Business Update
- Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK
- Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK and First Day of Dealings
- Mydecine Announces Conditional Approval of CSE Listing
More ▼
Key statistics
On Friday, Mydecine Innovations Group Inc (0NF0:STU) closed at 0.009, 500.00% above the 52 week low of 0.0015 set on Mar 14, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.009 |
---|---|
High | 0.009 |
Low | 0.009 |
Bid | 0.009 |
Offer | 0.0145 |
Previous close | 0.009 |
Average volume | 10.12k |
---|---|
Shares outstanding | 61.76m |
Free float | 61.16m |
P/E (TTM) | -- |
Market cap | 925.86k CAD |
EPS (TTM) | -1.06 CAD |
Data delayed at least 15 minutes, as of Jun 14 2024.
More ▼